HomeEXECUTIVES

EXECUTIVES

Radcliffe Group Ltd Appoints New Chief Technical Officer and Scientific Director

Radcliffe Group Ltd. COO Liam O'Neill comments: “Both David, myself, and the board of directors are delighted that Wells and Sean have chosen Radcliffe Group for the next chapter of their careers. Both have considerable reputations in their respective fields of specialism and it is a real coup to bring them into the leadership group of our growing company.

Katrina Church Offers 20 Plus Years of Experience: Secures CCO Position at Bioventus

Katrina Church brings more than 20 years of experience counseling public and private companies to ensure the highest compliance with industry standards, reporting and controls.

Dr. Nedal Safwat Is Named Chief Strategy Officer of Accelerate Diagnostics

Dr. Nedal Safwat joins Accelerate from BioMerieux, the world's leading microbiology diagnostics company.

Kevin Lofton Appointed to the Medtronic Board

Kevin Lofton will serve on the following committees of the board: Audit, Compensation, and Quality.

Therapix Biosciences Announces Replacement of its Board of Directors

Itschak Shrem was appointed as Chairman of the new board of directors, and Amitay Weiss, in addition to his membership with the board, will assume the position of Chief Executive Officer of the Company. 

Laura Coffey Is Appointed EVP CFO of The Vitamin Shoppe®: Offers Deep Financial Expertise

In her new role, Ms. Coffey will be responsible for Corporate Finance, Financial Planning and Analysis, Risk Management, Accounting, Internal Audit, Tax, and Real Estate.

Kristof Vercruysse New CEO of Persomed: Brings 20 Years of Biotech Industry Knowledge

Vercruysse brings almost 20 years of biotech industry knowledge and business development skills to Persomed. In this new role, his contribution will be crucial for the transition of the consortium into a new company.

Joerns Healthcare New CEO is Taylor Smith

Smith has over 25 years of successful leadership experience in the healthcare industry, and has demonstrated sustained growth for both the companies at which he has previously served and their customers.

Dr. Michael J. Sofia Appointed to the ViralClear Scientific Advisory Board

Currently, Dr. Sofia is a Co-founder and Chief Scientific Officer of Arbutus Biopharma, Inc., a company focused on the discovery and development of therapies to cure hepatitis B.